Business Law

British Drug Maker Indivior Indicted On Fraud And Conspiracy Charges In The U.S.

Posted on April 11, 2019 by Scott Slater III

NPR – Share prices for the British drugmaker Indivior plunged today on the London Stock Exchange. The drop came on news that the U.S. Justice Department indicted the company on fraud and conspiracy charges.

Waterbury Hosts Business and Human Rights Lecture Series

Posted on March 12, 2019 by Claire Hall, Courtney Akerley

An exterior view of the Waterbury Campus. (UConn photo)

Former Timex executive Bob Werner will be the keynote speaker during the second of a three-part lecture series on business and human rights, hosted at the UConn Waterbury campus. Continue Reading

Many sue OxyContin maker, but not its own city: Stamford

Posted on March 4, 2019April 2, 2019 by Scott Slater III

Westport News – Six of the state’s 10 largest cities, and hundreds of others across the country, have sued OxyContin maker Purdue Pharma. So has Connecticut’s attorney general and more than 30 of his counterparts.

Opioids: Boston trial opens what could be year of reckoning for executives

Posted on February 27, 2019March 1, 2019 by

The Guardian – Drug company executives appearing in court in Boston this week have been accused of running “a criminal enterprise” and putting greed before patient safety as they pushed prescription narcotics during the opioids crisis, blighting the health of America.

Purdue Pharma to research non-opioid treatments

Posted on January 9, 2019December 18, 2020 by Scott Slater III

Daily Heralds – Purdue Pharma, the controversial maker of OxyContin, and eyecare-pharmaceutical firm Ocular Therapeutix has announced a research partnership aiming to develop non-opioid pain treatments.

Read article

For Olympic Athlete the Goal is Dual Degrees

Posted on November 20, 2018January 3, 2023 by Camille Chill

Donn Cabral's professional running career has taken him around the world and provided some unique opportunities – including translating something for celebrity gymnast Simone Biles in Rio de Janeiro. (U.S. Olympics Photo) — Donn Cabral’s professional running career has taken him around the world and provided some unique opportunities – including translating something for celebrity gymnast Simone Biles in Rio de Janeiro. (U.S. Olympics Photo)

The day before he ran the 2018 Hartford Half Marathon, Donn Cabral attended a seminar called “A Lawyer’s Primer on Blockchain.” After he won the race, he headed home to tackle a take-home exam for a course called “Motivating Individuals and Teams.”Continue Reading

Investors Won’t Tolerate Corporate Misdeeds, Inhumanity

Posted on September 28, 2018October 10, 2018 by Claire Hall

Amy Domini, the keynote speaker for the Business & Human Rights Initative Symposium, speaks with former U.S. Senator Christopher Dodd.

Investment titan Amy Domini, widely considered a leading pioneer in socially responsible investing, came to UConn and shared what can only be described as good news.Continue Reading

Dean Mahoney ’09: A Passion for Entrepreneurship

Posted on September 26, 2018October 5, 2018 by Claire Hall

Dean Mahoney '09, pictured above, co-founded ‘Merican Mule in 2015. He is spearheading East Coast distribution of his company's namesake, an alcoholic beverage inspired by the Moscow Mule. (Nathan Oldham/UConn School of Business) — Dean Mahoney ’09, pictured above, co-founded ‘Merican Mule in 2015. He is spearheading East Coast distribution of his company’s namesake, an alcoholic beverage inspired by the Moscow Mule. (Nathan Oldham/UConn School of Business)

Sometimes in business, and in life, you have to swallow your mistakes. Even if there are 700 of them!Continue Reading

Purdue Pharma grapples with growing protests

Posted on August 27, 2018August 27, 2018 by

Stamford Advocate– Controversy surrounding Purdue Pharma’s role in the opioid crisis has spilled from the courtrooms into the streets.

Congressional Committee Investigates Purdue Pharma

Posted on August 7, 2018 by Melissa Ferrigno

Stamford Advocate– Purdue Pharma is facing questions from a Congressional committee investigating the opioid crisis, opening another round of scrutiny for the embattled maker of OxyContin.

School of Business

About the School

Campuses

News & Events

Contact

Undergraduate Degree

Graduate Programs

MBA Programs

Specialized Masters

Professional Development

Overview

Academic Areas

Faculty & Ph.D.s

Research Centers

Recruit

Centers, Institutes, & Initiatives

Experiential Learning